19-1438866-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1
The NM_001018.5(RPS15):c.63C>T(p.Asp21Asp) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0519 in 1,590,574 control chromosomes in the GnomAD database, including 2,450 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.054 ( 258 hom., cov: 32)
Exomes 𝑓: 0.052 ( 2192 hom. )
Consequence
RPS15
NM_001018.5 synonymous
NM_001018.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.251
Genes affected
RPS15 (HGNC:10388): (ribosomal protein S15) Ribosomes, the organelles that catalyze protein synthesis, consist of a small 40S subunit and a large 60S subunit. Together these subunits are composed of 4 RNA species and approximately 80 structurally distinct proteins. This gene encodes a ribosomal protein that is a component of the 40S subunit. The protein belongs to the S19P family of ribosomal proteins. It is located in the cytoplasm. This gene has been found to be activated in various tumors, such as insulinomas, esophageal cancers, and colon cancers. As is typical for genes encoding ribosomal proteins, there are multiple processed pseudogenes of this gene dispersed through the genome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Apr 2015]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -19 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.46).
BP6
Variant 19-1438866-C-T is Benign according to our data. Variant chr19-1438866-C-T is described in ClinVar as [Benign]. Clinvar id is 440243.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.251 with no splicing effect.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.0633 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0538 AC: 8190AN: 152170Hom.: 254 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
8190
AN:
152170
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0526 AC: 11189AN: 212584 AF XY: 0.0551 show subpopulations
GnomAD2 exomes
AF:
AC:
11189
AN:
212584
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0517 AC: 74306AN: 1438288Hom.: 2192 Cov.: 32 AF XY: 0.0530 AC XY: 37822AN XY: 713588 show subpopulations
GnomAD4 exome
AF:
AC:
74306
AN:
1438288
Hom.:
Cov.:
32
AF XY:
AC XY:
37822
AN XY:
713588
Gnomad4 AFR exome
AF:
AC:
1493
AN:
32828
Gnomad4 AMR exome
AF:
AC:
1051
AN:
42760
Gnomad4 ASJ exome
AF:
AC:
2180
AN:
25720
Gnomad4 EAS exome
AF:
AC:
1106
AN:
38506
Gnomad4 SAS exome
AF:
AC:
6392
AN:
83294
Gnomad4 FIN exome
AF:
AC:
3805
AN:
50592
Gnomad4 NFE exome
AF:
AC:
54725
AN:
1101128
Gnomad4 Remaining exome
AF:
AC:
3196
AN:
59288
Heterozygous variant carriers
0
3957
7915
11872
15830
19787
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
2044
4088
6132
8176
10220
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0539 AC: 8212AN: 152286Hom.: 258 Cov.: 32 AF XY: 0.0558 AC XY: 4152AN XY: 74466 show subpopulations
GnomAD4 genome
AF:
AC:
8212
AN:
152286
Hom.:
Cov.:
32
AF XY:
AC XY:
4152
AN XY:
74466
Gnomad4 AFR
AF:
AC:
0.0487101
AN:
0.0487101
Gnomad4 AMR
AF:
AC:
0.0426686
AN:
0.0426686
Gnomad4 ASJ
AF:
AC:
0.0853026
AN:
0.0853026
Gnomad4 EAS
AF:
AC:
0.0357281
AN:
0.0357281
Gnomad4 SAS
AF:
AC:
0.0693869
AN:
0.0693869
Gnomad4 FIN
AF:
AC:
0.078178
AN:
0.078178
Gnomad4 NFE
AF:
AC:
0.0538749
AN:
0.0538749
Gnomad4 OTH
AF:
AC:
0.076087
AN:
0.076087
Heterozygous variant carriers
0
392
784
1176
1568
1960
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
98
196
294
392
490
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
284
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
May 04, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not specified Benign:1
Feb 07, 2017
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Mutation Taster
=100/0
polymorphism (auto)
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at